MeSH term
Frequency | Condition_Probility | Blotting, Western | 4 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
DNA Repair | 7 | 1.0 |
Heterozygote | 3 | 0.0 |
Humans | 65 | 0.0 |
Radiation Tolerance/*genetics | 4 | 7.0 |
Research Support, Non-U.S. Gov't | 55 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 40 | 0.0 |
*Antigens, Nuclear | 21 | 14.0 |
Binding Sites | 9 | 0.0 |
*DNA Helicases | 26 | 12.0 |
DNA-Binding Proteins/genetics/*metabolism | 8 | 0.0 |
Dimerization | 5 | 0.0 |
Hela Cells | 13 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 5 | 0.0 |
*Saccharomyces cerevisiae Proteins | 21 | 1.0 |
DNA/metabolism | 2 | 0.0 |
DNA Repair/*physiology | 6 | 5.0 |
Protein Conformation | 2 | 0.0 |
Animals | 47 | 0.0 |
Mammals | 4 | 1.0 |
Amino Acid Sequence | 12 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Models, Molecular | 3 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Protein Binding | 8 | 0.0 |
Protein Structure, Quaternary | 2 | 1.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Base Sequence | 13 | 0.0 |
DNA Nucleotidyltransferases/*metabolism | 2 | 9.0 |
DNA Primers | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 6 | 0.0 |
Nuclear Proteins/metabolism | 5 | 0.0 |
*Recombination, Genetic | 9 | 2.0 |
VDJ Recombinases | 4 | 6.0 |
DNA/*genetics | 3 | 0.0 |
*DNA Repair | 21 | 3.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Mice | 22 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 4 | 2.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 3 | 2.0 |
Cells, Cultured | 6 | 0.0 |
DNA-Binding Proteins/deficiency/genetics/*metabolism | 2 | 16.0 |
Female | 5 | 0.0 |
Fibroblasts | 4 | 0.0 |
Male | 4 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Recombination, Genetic/*genetics | 3 | 4.0 |
Bleomycin/pharmacology | 2 | 7.0 |
*DNA Damage | 11 | 1.0 |
DNA Ligases/*metabolism | 8 | 40.0 |
Gamma Rays | 4 | 1.0 |
DNA Repair/*genetics | 6 | 1.0 |
Radiation Tolerance/genetics | 2 | 4.0 |
Androstadienes/*pharmacology | 2 | 9.0 |
CHO Cells | 12 | 0.0 |
Cell Line | 12 | 0.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Hamsters | 17 | 0.0 |
Mice, SCID | 5 | 0.0 |
*Transduction, Genetic | 2 | 2.0 |
DNA Ligases/metabolism | 4 | 12.0 |
DNA-Binding Proteins/metabolism | 6 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Saccharomyces cerevisiae/genetics | 4 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Adolescent | 2 | 0.0 |
Adult | 2 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Middle Aged | 2 | 0.0 |
Protein-Serine-Threonine Kinases/genetics | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Cell-Free System | 3 | 1.0 |
DNA/*metabolism | 5 | 1.0 |
Genetic Complementation Test | 4 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Antigens, Nuclear/physiology | 3 | 60.0 |
DNA-Binding Proteins/*physiology | 3 | 0.0 |
Phosphorylation | 8 | 0.0 |
Protein-Serine-Threonine Kinases/*physiology | 3 | 2.0 |
Cell Cycle | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Gene Rearrangement | 3 | 0.0 |
Binding, Competitive | 2 | 0.0 |
DNA Ligases/isolation & purification/*metabolism | 2 | 66.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Nuclear Proteins/*physiology | 3 | 2.0 |
Time Factors | 3 | 0.0 |
Apoptosis | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Phenotype | 5 | 0.0 |
Recombination, Genetic | 9 | 0.0 |
Receptors, Antigen, T-Cell/genetics | 2 | 2.0 |
Catalysis | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Mutation | 10 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/genetics/*metabolism | 2 | 4.0 |
Substrate Specificity | 5 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
*DNA Repair/genetics | 2 | 14.0 |
Radiation, Ionizing | 4 | 2.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
DNA Ligases/genetics/metabolism | 2 | 40.0 |
Cloning, Molecular | 5 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 8 | 0.0 |
Dose-Response Relationship, Radiation | 6 | 1.0 |
Sequence Deletion | 3 | 0.0 |
Gene Targeting | 2 | 0.0 |
Mutagenesis | 4 | 0.0 |
Chromosome Breakage | 2 | 2.0 |
DNA Replication | 2 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Androstadienes/pharmacology | 2 | 0.0 |
Chickens | 2 | 0.0 |
DNA Damage | 10 | 1.0 |
Kinetics | 2 | 0.0 |
Models, Genetic | 4 | 0.0 |
DNA-Binding Proteins/chemistry/*genetics/*metabolism | 2 | 5.0 |
Transfection | 4 | 0.0 |
X-Rays | 3 | 2.0 |
DNA Ligases/genetics/*metabolism | 2 | 28.0 |
Radiation Tolerance | 2 | 2.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
DNA Ligases/genetics | 2 | 22.0 |
DNA Repair/genetics | 5 | 2.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Immunoglobulin Joining Region/*genetics | 2 | 28.0 |
Immunoglobulin Variable Region/*genetics | 2 | 1.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
*Mutation | 2 | 0.0 |
*Chromosomes, Human, Pair 5 | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
VDJ Recombinases/metabolism | 2 | 100.0 |
Genotype | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Antigens, Nuclear/genetics | 2 | 100.0 |
Immunoblotting | 2 | 0.0 |
Protein Subunits | 2 | 0.0 |
